Research location
Veszprém
Hungary
Advertisement
Research activity in Veszprém
HungaryCureCurrent currently publishes aggregate city-level research activity for this location: 161 trials and 165 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Veszprém
161 linked trials · page 1 of 4A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid ArthritisNCT07276581 · 2025-12-15 · 1 site observation
RECRUITING
A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid ArthritisNCT06754462 · 2025-01-10 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid ArthritisNCT06028438 · 2023-08-15 · 1 site observation
COMPLETED
An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid ArthritisNCT05848258 · 2023-05-23 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With ObesityNCT05556512 · 2022-10-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)NCT04888585 · 2021-06-23 · 1 site observation
TERMINATED
MSB11456 in Participants With Moderately to Severely Active Rheumatoid ArthritisNCT04512001 · 2020-08-03 · 1 site observation
COMPLETED
TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATENCT04413617 · 2020-07-29 · 2 site observations
COMPLETED
Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)NCT04333147 · 2020-05-12 · 1 site observation
TERMINATED
Gan & Lee Evaluation of New Biosimilar for Type 1 LisproNCT04254380 · 2019-12-04 · 1 site observation
WITHDRAWN
Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) InhibitorsNCT04134728 · 2019-10-31 · 1 site observation
COMPLETED
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexateNCT03980483 · 2019-05-16 · 1 site observation
COMPLETED
A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With UpadacitinibNCT03823378 · 2019-05-13 · 1 site observation
TERMINATED
Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC SubjectsNCT03631199 · 2018-12-21 · 1 site observation
TERMINATED
A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid ArthritisNCT03682705 · 2018-10-08 · 1 site observation
COMPLETED
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-ANCT03447769 · 2018-03-16 · 1 site observation
TERMINATED
Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid ArthritisNCT03120949 · 2017-07-04 · 1 site observation
COMPLETED
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)NCT03071692 · 2017-03-23 · 1 site observation
TERMINATED
A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic AsthmaNCT03052725 · 2017-03-10 · 1 site observation
TERMINATED
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)NCT03057977 · 2017-03-06 · 1 site observation
COMPLETED
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)NCT03057951 · 2017-03-02 · 1 site observation
COMPLETED
MSB11022 in Moderate to Severe Rheumatoid ArthritisNCT03052322 · 2017-01-31 · 1 site observation
COMPLETED
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active DiseaseNCT02760433 · 2017-01-25 · 1 site observation
COMPLETED
Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To MethotrexateNCT02996500 · 2016-11-10 · 1 site observation
COMPLETED
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active DiseaseNCT02760407 · 2016-06-06 · 1 site observation
COMPLETED
Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid ArthritisNCT02744755 · 2016-03-31 · 1 site observation
COMPLETED
Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid ArthritisNCT02640612 · 2016-01-22 · 1 site observation
COMPLETED
Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood EosinophilsNCT02452190 · 2015-09-28 · 1 site observation
COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney DiseaseNCT02540993 · 2015-09-17 · 1 site observation
COMPLETED
Effects of Abatacept in Patients With Early Rheumatoid ArthritisNCT02504268 · 2015-09-03 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid ArthritisNCT02504671 · 2015-07-23 · 1 site observation
COMPLETED
An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid ArthritisNCT02518620 · 2015-07-01 · 1 site observation
COMPLETED
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).NCT02480153 · 2015-06-25 · 1 site observation
COMPLETED
Non-Interventional Study of Tocilizumab Subcutaneous (SC) Monotherapy in Participants With Rheumatoid Arthritis (RA)NCT02402686 · 2015-05-20 · 1 site observation
COMPLETED
A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney DiseaseNCT02358096 · 2015-03-17 · 1 site observation
COMPLETED
A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid ArthritisNCT02287922 · 2015-03-01 · 1 site observation
COMPLETED
Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis RemissionNCT02373813 · 2015-02-20 · 1 site observation
COMPLETED
Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)NCT02332590 · 2015-01-28 · 1 site observation
COMPLETED
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid ArthritisNCT02137226 · 2015-01-26 · 1 site observation
COMPLETED
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid ArthritisNCT02309359 · 2015-01-01 · 1 site observation
COMPLETED
Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.NCT02000622 · 2014-03-27 · 1 site observation
COMPLETED
A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX AloneNCT02066389 · 2014-03-26 · 1 site observation
COMPLETED
Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis ParticipantsNCT02065700 · 2014-02-25 · 1 site observation
COMPLETED
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic NephropathyNCT02065791 · 2014-02-17 · 1 site observation
COMPLETED
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Adults With Rheumatoid ArthritisNCT02049138 · 2014-01-24 · 1 site observation
COMPLETED
A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular EdemaNCT01994291 · 2013-11-01 · 1 site observation
TERMINATED
A Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported OutcomesNCT01930708 · 2013-10-31 · 1 site observation
COMPLETED
Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2)NCT01894516 · 2013-10-08 · 1 site observation
COMPLETED
Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid ArthritisNCT01999192 · 2013-10-01 · 1 site observation
TERMINATED
Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid ArthritisNCT01911234 · 2013-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.